The combination of obesity and foregut surgery puts patients undergoing bariatric surgery at high risk for postoperative pulmonary complications. Postoperative incentive spirometry (IS) is a ubiquitous practice; however, little evidence exists on its effectiveness.
higher risk for postoperative pulmonary complications such as hypoxemia, atelectasis, pneumonia, laryngospasm, respiratory distress, or the potential need for reintubation. 3, 4 Pulmonary complications after abdominal surgery are a major cause of morbidity and mortality. Foregut surgery in particular has high rates of pulmonary complications due to the close proximity to the diaphragm and the caudal location of the incision or port sites.
5 Laparoscopic foregut operations also predispose patients to postoperative pulmonary complications due to altered pulmonary mechanics from pneumoperitoneum and patient positioning. 6 By definition, bariatric surgery combines the risk factors of morbid obesity and foregut surgery, putting these patients at increased risk for postoperative pulmonary complications.
As a means to decrease postoperative pulmonary complications, Bartlett et al 7 first described the incentive spirometry (IS) device in 1970. 7 This device functions by encouraging patients to achieve maximal inspiration by providing visual feedback. Since its introduction, IS has gained widespread use in the postoperative period for the prophylaxis and treatment of respiratory complications. 8, 9 At present, postoperative IS is considered the standard of care and is incorporated into standardized bariatric surgery recovery protocols. 10 However, despite the ubiquitous use of IS in the postoperative period, data on its efficacy is conflicting, and high-quality evidence is lacking.
5,11
The intrinsic combination of morbid obesity and laparoscopic foregut surgery puts patients undergoing bariatric surgery at higher risk for postoperative pulmonary complications. The purpose of this study was to determine the effect of postoperative IS on the clinical, relevant pulmonary outcome measure of postoperative hypoxemia. Secondary outcome measures of arterial oxygen saturation (SaO 2 ) and 30-day postoperative pulmonary complications after bariatric surgery were also analyzed. We hypothesized that postoperative IS would have no effect on any of these outcomes. To answer this question, we conducted a randomized noninferiority clinical trial examining the effect of postoperative IS on these outcomes.
Methods

Study Design
This study was a single-center randomized clinical trial. All research and clinical care were performed at Lahey Hospital and Medical Center, Burlington, Massachusetts. The Surgical Weight Loss Center at Lahey Hospital is an American College of Surgeons Bariatric Surgery Center Network-accredited program that performs approximately 300 bariatric operations a year, with a bariatric surgery fellow or a general surgery resident assisting. Before the start of the project, the institutional review board of Lahey Hospital Medical Center approved all research (the full trial protocol is available in the Supplement), and all patients provided written informed consent. This study enrolled all consenting patients who underwent laparoscopic bariatric surgery from May 1, 2015 , to June 30, 2016 . No exclusion criteria other than failure to obtain consent were applied. We used a simple randomization scheme for group allocation. Before the start of the study, a computerrandomized list of group assignments was generated. After completion of the consent process, patients were randomized by sequentially accessing this list. Concealment of the next allocation and blinding during the consent processes was used ( Figure) .
Key Points
Question What is the effect of postoperative incentive spirometry on hypoxemia, oxygen saturation, and pulmonary complications after bariatric surgery?
Findings In this randomized noninferiority clinical trial of 224 patients undergoing bariatric surgery, no significant difference in the frequency of postoperative hypoxemia was found between patients who used incentive spirometry after surgery and those who did not. In addition, oxygen saturation levels and 30-day postoperative pulmonary complication rates did not differ between groups.
Meaning In its current implementation, use of postoperative incentive spirometry after bariatric surgery does not appear to decrease hypoxemia or postoperative pulmonary complications. 
Figure. Flow Diagram of the Study Design
Intervention and Control
Patients randomized to the control group received the current standard of care at our institution for postoperative use of IS. A postoperative nursing order was implemented to provide the patients with an IS device when the patient was "awake and alert" and for the patient to use the IS device "10 times every hour while awake." In addition, preoperative teaching and postoperative coaching and prompting were performed by the nursing staff. Patients randomized to the test group were not provided with an IS device (Figure) .
All patients received deep vein thrombosis prophylaxis with 5000 U of subcutaneous heparin sodium in the preoperative period. The anesthetic regimen was left to the discretion of the anesthesia team. Postoperatively, a standardized analgesia regimen was implemented, and no patient had epidural anesthesia. In addition to this analgesia protocol, a standardized recovery pathway of ambulation 3 times daily, diet advancement, and fluid management was implemented for both groups.
IS Use
To evaluate the frequency of IS use in the control group, a pilot study was conducted for 1 month before the start of this trial. Patients undergoing bariatric surgery received the same IS protocol used in the control group to record their device use. At the time of discharge, these logs were collected and analyzed.
Outcome Measures
The primary outcome measure of this study was the frequency of postoperative hypoxemia at 6, 12, and 24 postoperative hours. Hypoxemia was defined as an SaO 2 level of less than 92%. Because no strict definition of hypoxemia exists based on oxygen saturation, with a mean pulse oximeter precision of 2% 12 and less than 90% often used to represent hypoxemia in various studies, 13 a value of less than 92% was used.
Pulse oximetry measurements as opposed to arterial blood gas values were used because they were readily available, less costly, and less invasive. Data points needed to be measured within 1 hour before or after the determined time to be included. All SaO 2 levels were measured with patients discontinuing any supplemental oxygen therapy or positive airway pressure ventilation for 5 minutes and while sitting up with the head of their bed at more than 45°. This interval without supplementation was based on SaO 2 without supplemental oxygen reaching equilibration at 4.5 minutes 14 and 95% of changes in SaO 2 measurement to decreases in inspired oxygen occurring within 5 minutes. 15 In addition, the interval when a decrease in positive pressure ventilation results in an SaO 2 reaching equilibrium is about 5 minutes.
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The secondary outcome measure of SaO 2 as a continuous quantitative variable was examined from the values recorded in the above method. The secondary outcome measure of 30-day postoperative complications was defined as atelectasis, pneumonia, or the need for intubation. Atelectasis was defined as any radiology report mentioning pulmonary atelectatic changes regardless of clinical manifestations. Pneumonia was defined as radiographic or clinical documentation of pneumonia. Incidence of reintubation was obtained through the retrospective review of medical records.
Statistical Analysis
Before the start of the study, a noninferiority power calculation was performed to determine sample size. Review of the literature showed a 10% baseline proportion of patients after bariatric surgery with SaO 2 levels less than 92%. [17] [18] [19] A minimum of 112 patients per group provided a power of more than an 80% (β = 0.20) chance of rejecting a false null hypothesis. This level was based on detection of a clinically significant Δ statistic of 10% between groups with an expected SD of pulse oximetry values of 2%. 12,20 We used 2-tailed paired t tests and χ 2 tests to compare means of continuous variables and distributions of binary variables between both groups, respectively. We used Fisher exact tests to compare categorical variables between both groups. P < .05 was considered statistically significant. Generalized linear models were used to evaluate outcomes over time with adjustment for multiple measures on each patient. A generalized linear mixed model with main effects for treatment and time (6, 12, and 24 hours) and the 2-factor interaction was used to evaluate the effect of IS use on postoperative hypoxemia. Because hypoxemia status was binary, the model assumed a binomial distribution for the outcome. The model adjusted for repeated measures over time on each person and used an autoregressive covariance structure.
We used a multivariable logistic regression model with a stepwise selection process to choose among candidate predictor variables that had unadjusted P < .15 for the outcome of any postoperative hypoxemia. This model included no IS as a candidate variable. The candidate variables included age, body mass index, asthma, chronic obstructive pulmonary disease (COPD), baseline SaO 2 level, and no use of IS. For the variable selection process, limits were set to allow variables with adjusted P = .10 to enter and stay in the model. Power analysis and statistical analysis were performed by a blinded data assessor from the Tufts University Clinical and Translational Science Institute. All analyses were performed using SAS for Windows (version 9.4; SAS Institute Inc).
Results
Study Population
From May 1, 2015 , to June 30, 2016 (Figure) . A total of 112 patients were randomized to the control group and 112 were randomized to the test group. Baseline characteristics of each group were similar, with no statistically significant differences in their demographics ( Figure) . The control group was noted to have more patients with COPD when compared with the test group (5 patients [4.5%] vs 0; P = .02). For all other
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IS Use
During the pilot study, a total of 16 patients underwent bariatric surgery. Of those 16 patients, log sheets on IS use were collected from 12. On postoperative day 1, the mean frequency of IS use was 4.1 times per day. On postoperative day 2, mean frequency of IS use was 10.4 times per day.
Postoperative Hypoxemia
We found no statistically significant differences in frequency of hypoxemia observed between groups for all points among patients with available measurements ( Table 2) . At 6 postoperative hours, 13 of 109 patients (11.9%) in the control group were hypoxemic compared with 11 of 106 patients (10.4%) in the test group (P = .72). At 12 postoperative hours, 6 of 112 patients (5.4%) in the control group were hypoxemic compared with 9 of 110 patients (8.2%) in the test group (P = .40). At 24 postoperative hours, 4 of 108 patients (3.7%) in the control group were hypoxemic compared with 5 of 108 patients (4.6%) in the test group (P = .73).
Postoperative SaO 2 Level
We observed no statistically significant differences in mean SaO 2 levels between groups for all times (Table 2) . At 6 postoperative hours, patients in the control group had a mean (SD) SaO 2 level of 94.9% (3.2%) compared with a mean of 94.9% (2.9%) for patients in the test group (P = .99). At 12 postoperative hours, patients in the control group had a mean (SD) SaO 2 level of 95.4% (2.2%) compared with a mean of 95.1% (2.5%) for patients in the test group (P = .40). 
Postoperative Pulmonary Complications
We observed no differences between the rates of 30-day postoperative pulmonary complications between groups ( Table 3) . Eight of 112 patients (7.1%) in the control group had postoperative pulmonary complications, including 7 occurrences of atelectasis (6.%), 1 of pneumonia (0.9%), and no reintubations. For the test group, 4 of 112 patients (3.6%) had postoperative pulmonary complications, all consisting of atelectasis (P = .24 for the difference between groups).
Univariate and Multivariate Logistic Regression Models
We found no significant interaction of treatment and time (P = .41), with no significant variation between the different evaluation points. We found no significant difference in hypoxemia between the control and test groups (P = .49; adjusted mean hypoxemia with or without IS, 5.8% vs 7.6%). For the multivariate logistic regression model when the variable selection process was run, the only variable that reached significance was baseline SaO 2 level. A single patient was hypoxemic preoperatively and hypoxemic at 6 and 24 postoperative hours. Using the unadjusted logistic regression model for each potential predictor variable, preoperative hypoxemia had a 100% specificity for postoperative hypoxemia based on this single patient. However, after controlling for this variable, none of the other variables had adjusted significant associations with hypoxemia with the outcome at the level of P <.10.
Discussion
We present findings from, to our knowledge, the first reported randomized clinical trial to evaluate the effect of IS use after bariatric surgery. We found no significant difference in the frequency of postoperative hypoxemia among patients using an IS device after surgery compared with those who did not. In addition, we did not observe a difference in SaO 2 level or the rate of 30-day postoperative pulmonary complications between patients using an IS device after surgery compared with those who did not. These findings support our null hypothesis that postoperative IS use has no significant effect on hypoxemia or SaO 2 after bariatric surgery. Based on these findings, we do not recommend the routine use of IS in its current implementation after bariatric surgery. In addition, we question its routine use for other laparoscopic foregut procedures.
These findings are consistent with the current published literature on IS use postoperatively. A 2007 Cochrane review of randomized clinical trials of IS in adult patients undergoing upper abdominal surgery 11 found that participants receiving IS had the same rates of clinical or pulmonary complications as those who did not. In bariatric surgery specifically, preoperative IS use has been shown to have no effect on postoperative lung function. 21 Despite the lack of evidence, use of IS is a common practice. [8] [9] [10] At our institution, $33 491 was spent on purchasing these devices in the 2013-2014 fiscal year. In a setting where resources are limited or are being conserved, IS use has not been shown to be effective. 22 Also, time is spent by health care workers in teaching, encouraging, and educating about these devices with little proven benefit. In addition to the time and monetary costs, these disposable devices go against many initiatives to reduce the amount of the environmental effect of health care. By definition, bariatric operations combine the risk factors for postoperative complications of obesity 3,4 and foregut surgery. 5, 6 This innate combination puts these patients at increased risk for postoperative pulmonary complications and hypothetically would make them ideal candidates for postoperative IS benefit. If no benefit is seen in this high-risk population, we postulate that the use of IS postoperatively in its current form for similar-or lower-risk operations would be of no benefit.
Limitations
This study has several limitations. Although postoperative hypoxemia and SaO 2 level are both meaningful clinical measures, postoperative pulmonary complications are of more clinical significance. However, pulmonary complications after bariatric surgery are very rare, with the American College of Surgeons National Surgical Quality Improvement Project reporting a 0.2% pneumonia rate, 0.2% reintubation rate, and 0.1% requiring ventilation for more than 48 hours in 2014.
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Owing to the infrequency of these complications, this study was not powered to detect this difference; to power a study with postoperative pulmonary complications as a primary outcome, a very large sample size would be needed. Therefore, we opted to use hypoxemia as our primary outcome measure. At our institution, patients with SaO 2 levels less than 92% receive supplemental oxygen therapy, thus making this outcome measure of clinical significance. 
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Another limitation is that patients with COPD were not stratified during randomization. As such, significantly more patients with COPD were in the control group (5 of 112) compared with the test group (0 of 112). Analysis of these patients with COPD revealed more frequent hypoxemia and lower SaO 2 levels but without any 30-day postoperative pulmonary complications. However, when these patients were excluded from analysis, we found no significant difference between groups in any outcome measures. In addition, a multivariate logistic regression model did not identify COPD as having a significant association with hypoxemia. Thus, COPD is unlikely to have acted as a confounding variable; however, because few patients with COPD were enrolled, extrapolation of our results to patients with COPD is limited.
For patients in the control group, adherence to IS use was lower than protocol determined. The control group was ordered to use the IS device 10 times per hour based on our preexisting institutional policy. However, observed compliance was much lower, with a mean of 4.1 times per day on the first postoperative day and a mean of 10.4 times per day on the second day. This rate of adherence would appear to be poor; however, a standardized and evidence-based frequency of IS use is not defined.
11 This lack of definition may have been attributable to a combination of factors, including variable length of hours in the first postoperative day because some operations were finished later in the day. Also, patients slept more on the first postoperative day; thus, IS was not used as frequently. For the purposes of this study, a frequency of 10 times per hour was used because this was a preexisting protocol at our institution, and our nurses were familiar with these instructions. This protocol was continued for the control group. However, review of the literature reveals a wide range of reported values from 4 times per day 24 to every 6 minutes while awake or 10 times per hour. 25 Although controls used IS less frequently than instructed by protocol, they still fell within the reported range of use and still represent an adequate control group for device use. However, the results of this study may be a consequence of that low adherence rate in the control group, with the possibility of increased adherence altering the results. Even in this study with structured teaching, adherence was difficult. This low rate of compliance may reflect a more universal problem with IS and may contribute to its lack of effectiveness. The secondary outcome of 30-day postoperative pulmonary complications may have been confounded by patients seeking care at other facilities. After discharge, appointments are scheduled at 1 and 2 weeks from discharge; in our centers, annual rates of 30-day follow-up tracked by the American Society for Metabolic and Bariatric Surgery is more than 90%. We have no way of determining whether some patients presented to another facility with pulmonary complications, but we believe this occurrence to be a low number.
Conclusions
Our findings did not demonstrate any effect of IS on postoperative hypoxemia or SaO 2 level. Based on these findings, we do not recommend the routine use of IS after bariatric surgery. With health care moving toward a more evidence-based, economically driven, and environmentally sustainable field, this study adds evidence to the concept that IS should not be universally used in all patients undergoing surgery and does not appear to be necessary in elective bariatric surgical procedures. to IS in preventing postoperative pulmonary complications. Still, IS is believed to be the standard of care and is included in emerging enhanced recovery pathways for bariatric surgery. 6 It is timely that, in this issue of JAMA Surgery, Pantel and colleagues 7 report their randomized clinical study to assess the effect of IS on patients undergoing bariatric surgery. They randomized postoperative patients to use or nonuse of IS and found no difference in the occurrence of postoperative hypoxemia (arterial oxygen saturation level of <92%) at 6, 12, and 24 postoperative hours or the rate of 30-day postoperative pulmonary complications. They cite the annual cost of incentive spirometers was $33 491 at their institution and make an argument against the routine use in patients undergoing bariatric surgery. Proponents of IS might point out that the results are not translatable to patients undergoing open bariatric procedures or that the study is not sufficiently powered to detect differences in postoperative pulmonary complications. Were a larger study performed, even a small reduction in postoperative pneumonia would negate the cost containment logic. However, the more compelling data for continuing routine IS may be found by a quick internet search using keywords lawsuit and incentive spirometry.
Research Objectives / Specific Aims / Outcome Measures: The primary objective of this study is to evaluate the impact of incentive spirometry on postoperative respiratory status in bariatric surgery. The secondary objective is to evaluate the impact of incentive spirometry on postoperative respiratory complications in bariatric surgery. We hypothesize that the use of postoperative incentive spirometry in bariatric surgery has no impact on postoperative respiratory status or rates of pulmonary complications. The primary outcome measure of postoperative respiratory status is defined as the percent of subjects with oxygen saturation less than 92% at 6, 12 and 24 hours after their operation. This threshold is being used, as it is a clinically significant point at which if patients fall below this value they are placed on supplemental oxygen. At the request of the IRB a pilot study was conducted to evaluate the occurrence rate of the primary outcome measure of oxygen desaturation below 92%. A retrospective analysis was performed on all patients who underwent bariatric surgery, from the implementation of EPIC on 3/31/2015 to the submission of this project on 4/24/15. Of those 23 patients 34.7% (8/23) had oxygen saturations below 92% at 6 hours postoperatively. At 12 hours postoperatively, 30% (7/23) had oxygen saturations below 92%. At 24 hours postoperatively there were no patients with oxygen saturations below 92%. These findings are consistent with our previous review of the literature (Zoremba 2009 , Sucandy 2013 . Based on these pilot study findings we concluded that postoperative oxygen saturation below 92% is a commonly occurring event, the occurrence at Lahey is similar to previously reported rates, and that this proposed study is adequately powered.
The secondary outcome measures will include postoperative respiratory complications (atelectasis found on chest imaging, pneumonia, or re intubation) up to 30 days postoperatively. Additionally time to wean off supplemental oxygen, oxygen saturation comparison between groups, and respiratory rate will all be secondary outcome measures.
Background Information / Significance / Scientific Rationale: An incentive spirometer is a device in which a patient inspires slowly and as deeply as possible, and then holds their breath for 2-6 seconds. Use of these devices is speculated to improve pulmonary function in the postoperative period, though data to support this is lacking (Cochrane Database 2014). Patients at risk for postoperative decline in respiratory function and postoperative respiratory complications are the morbidly obese and patients undergoing foregut surgery. Thus bariatric surgery provides a cohort with both of these risk factors. While currently all bariatric surgery patients at Lahey receive these devices and they are cited in the literature as part of enhanced recovery protocols for bariatric surgery, no data has supported their benefit in bariatric surgery. Data has shown that their use preoperatively has no benefit on postoperative lung function (Cattano 2010) . Additionally the CDC states that their use is not associated with significant improvements of inspiratory capacity prior to laparoscopic bariatric surgery and may not be useful to prevent postoperative decrease in lung function (Restrepo 2011) .
Despite the lack of evidence supporting the efficacy of these devices Lahey Clinic and bariatric surgery centers across the country continue to use these devices. Lahey Burlington spent $33,491.13 on purchasing these devices in the 2013-2014 fiscal year. In addition to this monetary cost, time is spent in the preoperative bariatric clinic by MD or advanced practitioners in teaching about the use of incentive spirometers. Once patients arrive on the surgical floor, nurses are ordered to have the patients use the Study Title: The effect of postoperative incentive spirometry on pulmonary function and pulmonary complications in bariatric surgery Protocol Version Number: #3 Protocol Date: 7/17/15 #SS116-F Protocol Template device every 6 minutes for a total of 10 times per hour while awake. This frequency of device use is recommended by the Cleveland Clinic, however the National Institute of Health via their MedlinePlus website recommends using the device once every 1 to 2 hours after surgery. Regardless of frequency this still requires significant nursing time and thus resources in the early postoperative period. At the request of the IRB, patient compliance with the standard order of device use every 6 minutes was evaluated. As the current order is to be the control, having a baseline assessment of actual use provides for a better control. Currently the spirometer has a paper log included in the package provided for by the manufacturer for patient's to record how often and at what volumes they are using the device. We had our nursing colleagues provide these logs to 10 sequential postoperative bariatric patients. These were then collected at the time of discharge. Of the 10 logs distributed 5 were returned for analysis. Results from these indicate that the actual mean compliance was 5 times per day (range 3 to 7) on postoperative day 1, on postoperative day 2 patients on average used the device 12 times per day (range 9 to 16). While this is significantly less than the current order of 10 times per hour, it is in line with the National Institute of Health recommendations of once every 1 to 2 hours. From this data we conclude that the current actual use of incentive spirometer is adequate, and thus serves as an appropriate control and is in line with the standard of care.
By demonstrating the lack of benefit of postoperative incentive spirometry, this study would eliminate the monetary and time resources consumed by this unnecessary device. Additionally, this study would add to the knowledge base and help to replace surgical dogma with evidence-based practice.
Participant Selection / Eligibility: All patients cleared for bariatric surgery will be potential subjects. There are no exclusion criteria.
Subject Enrollment / Consent Process / Screening / Randomization: Subjects will be approached regarding interest in study participation in the bariatric clinic once they have been cleared to undergo bariatric surgery per the usual screening process.
The attending surgeon or bariatric fellow or the primary investigator will perform the informed consent process (see designated co-investigators). This process may occur in the General Surgery clinic when potential subjects have their 30 minute scheduled preoperative appointment prior to going to the operating room.,, or subjects will be provided with a copy of the informed consent document to take home and review at their leisure Subjects who chose to take the consent form to review, will be asked to sign consent on the day of their procedure, while they are awaiting surgery. The nature of their condition will be discussed; the potential risks and benefits of the study will be explained to subjects before signing the research informed consent. The options including not enrolling, enrolling now, and the option to withdraw from the study at any time for any reason will be explained to subjects as well. Once they have consented a consent form will be signed and the subject provided a copy.
Randomization will occur at the time a patient is enrolled in the study. Subjects will be randomized with simple randomization from a randomly generated number list to ensure equal number of subjects in each group. Study Design / Procedures: Once a subject is enrolled they will be randomized at that time to either the control or the study group. Subjects in the control group will receive the current bariatric postoperative order set which includes the nursing order for "Incentive spirometry 10 times every hour while awake". Additionally these control subjects will be provided with the paper log included in the package produced by the manufacturer for patient's to record how often and at what volumes they are using the device. Subjects randomized to the study group will receive a modified postoperative orders set where this line will be removed. Education and information about the study and the order not to provide patients in the study group with the device will be provided to Nurses and Nursing Assistant in both the Post Anesthesia Care Unit and on the surgical floor. This will be the only difference between the groups. Biometric data will be used to establish baseline characteristics of subjects. This will be obtained from the medical record and include subject's gender, age, BMI, smoking status, history of obstructive sleep apnea, and the operation they are undergoing. Baseline pulmonary data will be collected from the already established protocol of measuring preoperative oxygen saturation on room air and respiratory rate in the OR hold area. Postoperative data routinely collected on oxygen saturation and respiratory rate will be used. The primary outcome oxygen saturation will be measured with subjects off of supplemental oxygen for 5 minutes with head of bed at 30° at 6,12 and 24 hours postoperatively. Education will be provided to Nurses and Nurse Assistants on standardizing timing and measuring these vitals. Additionally, secondary outcomes will be measured through Study Title: The effect of postoperative incentive spirometry on pulmonary function and pulmonary complications in bariatric surgery Protocol Version Number: #3 Protocol Date: 7/17/15 #SS116-F Protocol Template review of subject's medical record looking for: respiratory rate, time to wean off supplemental oxygen, and postoperative respiratory complications (atelectasis found on chest imaging, pneumonia, or re intubation).
Study Calendar / Schematic / Schedule: Please see attached schematic. Enrollment will start once IRB approval is obtained. Subjects will be enrolled in the study for their entire inpatient stay following bariatric surgery. This is on average 2 to 3 days but can be up to 1 week. If subjects are readmitted within 30 days of their surgery any pulmonary complications at time of admission will be included as well.
Potential Risks and Discomforts: Potential risks include atelectasis, pneumonia, re-intubation. These are risks inherent to the operation and there is no data to support that incentive spirometry reduces the risks of these events following bariatric surgery. Thus there is minimal risk to subjects in taking away a device which has no proven benefit.
Potential Benefits: There is no potential benefit to subjects. This study will benefit Lahey by reducing financial and time costs associated with these devices. Additionally it will help to replace surgical dogma with evidence-based practice.
Statistical Analysis:
The creation of the statistical plan was made with recommendations and advice from the Tufts CTSI. Sample size and power was calculated using a 2% difference between groups as acceptable, with a 90% power using a one-sided T-test with alpha of 0.05 (this is a non-inferiority test and there is no concern about the other side of the distribution). In order to power this study 18 subjects per group are needed to evaluate the continuous outcome of difference in O2 saturation means between groups.
To look at a binary outcome (and possibly more clinically relevant outcome) of what % subjects in each group have O2 saturations < 92%, I am assuming < 30% of persons getting IS will have O2 saturation < 92%. This gives a delta of 10% (i.e. up to 40% of persons not getting IS have saturations < 92%) and thus a power of 112 subjects per group to show this at 80% power with an alpha of 0.05 is needed. This is why I have chosen to include 120 subjects per group.
Randomization will occur at the time a patient is enrolled in the study. Subjects will be randomized with simple randomization from a randomly generated number list.
Once data has been collected on baseline characteristics (gender, age, BMI, smoking status, history of obstructive sleep apnea, operation), groups will be compared via a two-sided T-test with alpha of 0.05. The primary outcome of O2 saturation at each time point will be compared between groups with a two-sided Ttest with alpha of 0.05. To look at what % subjects in each group have O2 saturations < 92% postoperatively, a chi square test with delta of 10% and alpha of 0.05 will be used. Data Management: Data will be managed by Haddon Pantel on a secure spread sheet in a password protected folder on the Lahey General Surgery shared drive. Subjects will be assigned a number and there will be no identifying information on this spreadsheet.
Data and Safety Monitoring and Quality Assurance:
Again data will be stored on a secure Lahey server in a password protected folder. There will be no quality assurance, data will be eventually submitted for peer review publication and that will ensure the quality of the work.
